Cardiac Rhythm Management Market Size, Share, & COVID-19 Impact Analysis - Global - 2022-2028 - MedSuite - Includes: Pacemakers, Cardiac Ablation Catheters, and 6 more
The global cardiac rhythm management, electrophysiology & cardiac ablation market is valued at approximately $17.5 billion in 2021 and is expected to grow at a CAGR of 4.9% to reach over $24 billion during the forecast period. The full report suite on this market covers various products such as pacemakers, implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy devices (CRTs), cardiac leads, implantable loop recorders (ILRs), electrophysiology (EP) lab systems, diagnostic electrophysiology (EP) catheters, and cardiac ablation catheters. With an increasing demand for advanced medical devices for the treatment of heart diseases, the market for cardiac rhythm management, electrophysiology & cardiac ablation is poised for steady growth in the coming years.
MARKET REPORT DATA TYPES INCLUDED
Unit Sales, Average Selling Prices, Market Size & Growth Trends
Procedure Numbers
COVID-19 Impact Analysis
Market Drivers & Limiters
Market Forecasts Until 2028, and Historical Data to 2018
Recent Mergers & Acquisitions
Company Profiles and Product Portfolios
Leading Competitors
GLOBAL CARDIAC RHYTHM MANAGEMENT MARKET TRENDS
The cardiac rhythm management and ablation sector is rapidly evolving with new technologies emerging on a regular basis. In the last decade, there have been significant improvements in the capabilities and battery lifespan of pacemakers and ICDs. Over the forecast period, the adoption of wireless technology is expected to make it easier for doctors to monitor and adjust the functions of these devices. This will likely result in higher sales of pacemakers and ICDs, as well as maintain high selling prices due to the incorporation of advanced technologies. The continued development and integration of new technologies will be a key driver of growth in this market in the coming years.
GLOBAL CARDIAC RHYTHM MANAGEMENT MARKET SHARE INSIGHTS
The global cardiac rhythm management device market is dominated by three major players - Medtronic, Abbott, and Boston Scientific. Out of the more than 60 companies analyzed in this market, these three companies hold a significant market share and are recognized as the industry leaders.
Medtronic has maintained a strong presence in the total market for cardiac rhythm management (CRM), electrophysiology (EP) and ablation through brand recognition, strong customer support and a large sales force.
MARKET SEGMENTATION SUMMARY
While this report suite contains all global cardiac rhythm management devices data, each of the markets is also available as a stand-alone report, a MedCore.
Pacemaker Market – Includes:
Single-Chamber Pacemaker, Dual-Chamber Pacemaker, and Leadless Pacemaker
Implantable Cardioverter Defibrillator Market – Includes:
Single-Chamber ICD, Dual-Chamber ICD, and S-ICDs
Cardiac Resynchronization Therapy Device Market – Includes:
CRT-P, CRT-D
Cardiac Lead Market – Includes:
Pacing Lead, Defibrillation Lead, and LV Lead
Implant Loop Recorder Market
Electrophysiology Lab System Market – Includes:
3D Mapping System, EP Recording System
Diagnostic Electrophysiology Catheter Market – Includes:
Conventional EP Catheter, Advanced EP Catheter, and ICE Catheter
Cardiac Ablation Catheter Market – Includes:
RF Ablation Catheter, Cryoablation Catheter
RESEARCH SCOPE SUMMARY
Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year: 2021
Forecast: 2021-2028
Historical Data: 2018-2021
Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.
WHY CHOOSE IDATA?
Experts Only– iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
- executive summary
- Global Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Overview
- Competitive Analysis
- Market Trends
- Market Developments
- Procedures Included
- Markets Included
- Regions Included
- Version History
- research methodology
- Step 1: Project Initiation & Team Selection
- Step 2: Prepare Data Systems and Perform Secondary Research
- Step 3: Preparation for Interviews & Questionnaire Design
- Step 4: Performing Primary Research
- Step 5: Research Analysis: Establishing Baseline Estimates
- Step 6: Market Forecast and Analysis
- Step 7: Identify Strategic Opportunities
- Step 8: Final Review and Market Release
- Step 9: Customer Feedback and Market Monitoring
- impact of covid-19 on THE global Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market
- 2.1 Introduction
- 2.2 Regional Profiles
- 2.3 Analysis By Market Segment
- 2.3.1 Worst Case Scenario
- 2.3.2 Base Case Scenario
- 2.3.3 Best Case Scenario
- Disease Overview
- 3.1 Introduction
- 3.2 Types of Arrhythmias
- 3.2.11 Atrial Fibrillation
- 3.2.12 Bradycardia
- 3.2.13 Conduction Disorders
- 3.2.13.1 Bundle Branch Block
- 3.2.13.2 Heart Block
- 3.2.13.3 Long QT Syndrome (LQTS)
- 3.2.14 Premature Contractions: PACs and PVCs
- 3.2.15 Tachycardia
- 3.2.16 Ventricular Fibrillation
- 3.2.17 Other Rhythm Disorders
- 3.2.17.1 Adams-Stokes Disease
- 3.2.17.2 Atrial Flutter
- 3.2.17.3 Sick Sinus syndrome
- 3.2.17.4 Sinus Arrhythmia
- 3.2.17.5 Wolff-Parkinson-White Syndrome (WPW)
- 3.2.18 Types of Arrhythmia in Children
- 3.3 Heart Failure
- 3.4 Cardiac Arrest
- 3.5 Patient Demographics
- 3.5.11 Atrial Fibrillation
- 3.5.12 Bradycardia
- 3.5.13 Conduction Disorders
- 3.5.14 Premature Contractions – PACs and PVCs
- 3.5.15 Tachycardia
- 3.5.16 Ventricular Fibrillation
- 3.5.17 Other Rhythm Disorders
- 3.5.18 COVID & Arrhythmias
- 3.5.19 Heart Failure and Cardiac Arrest
- Product Assessment
- 4.1 Introduction
- 4.2 Product Portfolios
- 4.2.1 Pacemakers
- 4.2.2 Implantable Cardioverter Defibrillators (ICDs)
- 4.2.3 Cardiac Resynchronization Therapy (CRT) Devices
- 4.2.4 Cardiac Leads
- 4.2.5 Implantable Loop Recorders
- 4.2.6 Electrophysiology Lab Systems
- 4.2.6.1 Introduction
- 4.2.6.2 3D Mapping Systems
- 4.2.6.3 EP Recording Systems
- 4.2.6.4 Remote Steering Systems
- 4.2.6.5 RF Ablation Generator
- 4.2.6.6 ICE Systems
- 4.2.7 Diagnostic EP Catheters
- 4.2.7.1 Introduction
- 4.2.7.2 Diagnostic EP Catheters
- 4.2.7.3 ICE Catheters
- 4.2.8 Cardiac Ablation Catheters
- 4.2.8.1 Introduction
- 4.2.8.2 RF Ablation Catheters
- 4.2.8.3 Alternative Energy Catheters
- 4.2.8.4 High Intensity Focused Ultrasound
- 4.3 Regulatory Issues and Recalls
- 4.3.1 Abbott
- 4.3.1.1 Pacemakers
- 4.3.1.2 Implantable Cardioverter Defibrillators (ICDs)
- 4.3.1.3 Cardiac Resynchronization Therapy (CRT) Devices
- 4.3.1.4 Cardiac Leads
- 4.3.1.5 EP Lab Devices
- 4.3.1.6 Cardiac Ablation Catheter
- 4.3.2 Biosense Webster
- 4.3.2.1 EP Lab Devices
- 4.3.2.2 Diagnostic EP Catheters
- 4.3.2.3 Cardiac Ablation Catheters
- 4.3.3 Boston Scientific
- 4.3.3.1 Pacemakers
- 4.3.3.2 Implantable Cardioverter Defibrillators (ICDs)
- 4.3.3.3 Cardiac Resynchronization Therapy (CRT) Devices
- 4.3.3.4 Cardiac Leads
- 4.3.3.5 EP Lab Devices
- 4.3.3.6 RF Ablation Catheter
- 4.3.4 Medtronic
- 4.3.4.1 Pacemakers
- 4.3.4.2 Implantable Cardioverter Defibrillators (ICDs)
- 4.3.4.3 Cardiac Resynchronization Therapy (CRT) Devices
- 4.3.4.4 Cardiac Leads
- 4.3.4.5 EP Lab Devices
- 4.3.5 MicroPort
- 4.3.5.1 Implantable Cardioverter Defibrillators (ICDs)
- 4.3.5.2 Cardiac Resynchronization Therapy (CRT) Devices
- 4.4 Clinical Trials
- 4.4.1 Pacemakers
- 4.4.2 Implantable Cardioverter Defibrillators (ICDs)
- 4.4.3 Cardiac Resynchronization Therapy (CRT) Devices
- 4.4.4 Cardiac Leads
- 4.4.5 Lab Systems
- 4.4.5.1 3D Mapping Systems
- 4.4.5.2 EP Recording Systems
- 4.4.5.3 RF Ablation Generators
- 4.4.5.4 ICE Systems
- 4.4.6 Diagnostic EP Catheters
- 4.4.6.1 Diagnostic Catheter
- 4.4.7 Cardiac Ablation Catheter
- 4.4.7.1 RF Ablation Catheters
- 4.4.7.2 Cryoablation Catheters
- 4.4.7.4 Laser Ablation Catheters
- Global Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Overview
- 5.1 Introduction
- 5.2 Market Overview & Trend Analysis
- 5.2.1 By Segment
- 5.2.2 By Region
- 5.3 Drivers and Limiters
- 5.3.1 Market Drivers
- 5.3.2 Market Limiters
- 5.4 Competitive Market Share Analysis
- 5.5 Mergers and Acquisitions
- 5.6 Company Profiles
- 5.6.1 Abbott
- 5.6.2 Biosense Webster
- 5.6.3 Biotronik
- 5.6.4 Boston Scientific
- 5.6.5 GE Healthcare
- 5.6.6 Medtronic
- 5.6.7 MicroPort
- 5.7 SWOT Analysis
- 5.7.1 Abbott
- 5.7.2 Biosense Webster
- 5.7.3 Biotronik
- 5.7.4 Boston Scientific
- 5.7.5 GE Healthcare
- 5.7.6 Medtronic
- 5.7.7 MicroPort
- Pacemaker Market
- 6.1 Executive Summary
- 6.1.1 Global Pacemaker Market Overview
- 6.1.2 Competitive Analysis
- 6.1.3 Procedures Included
- 6.1.4 Markets Included
- 6.1.5 Regions Included
- 6.2 Introduction
- 6.2.1 Single and Dual-Chamber Devices
- 6.2.2 MRI-Compatible Pacemaker
- 6.2.3 Leadless Pacemaker
- 6.2.4 Initial Placement and Replacement of Pacemakers
- 6.3 Procedure Numbers
- 6.3.1 Total Pacemaker Placement Procedures
- 6.3.2 Initial Placement Pacemaker Procedures
- 6.3.3 Replacement Pacemaker Procedures
- 6.4 Market Overview
- 6.4.1 By Segment
- 6.4.2 By Region
- 6.5 Market Analysis and Forecast
- 6.5.1 Total Pacemaker Market
- 6.5.2 Single-Chamber Pacemaker Market
- 6.5.2.1 Initial Placement Single-Chamber Pacemaker Market
- 6.5.2.2 Replacement Single-Chamber Pacemaker Market
- 6.5.3 Dual-Chamber Pacemaker Market
- 6.5.3.1 Initial Placement Dual-Chamber Pacemaker Market
- 6.5.3.2 Replacement Dual-Chamber Pacemaker Market
- 6.5.4 Leadless Pacemaker Market
- 6.5.4.1 Initial Placement Leadless Pacemaker Market
- 6.5.4.2 Replacement Leadless Pacemaker Market
- 6.6 Drivers and Limiters
- 6.6.1 Market Drivers
- 6.6.2 Market Limiters
- 6.7 Competitive Market Share Analysis
- Implantable Cardioverter defibrillator Market
- 7.1 Executive Summary
- 7.1.1 Global Implantable Cardioverter Defibrillator Market Overview
- 7.1.2 Competitive Analysis
- 7.1.3 Procedures Included
- 7.1.4 Markets Included
- 7.1.5 Regions Included
- 7.2 Introduction
- 7.3 Procedure Numbers
- 7.3.1 Total ICD Placement Procedures
- 7.3.2 Initial Placement ICD Procedures
- 7.3.3 Replacement ICD Procedures
- 7.4 Market Overview
- 7.4.1 By Segment
- 7.4.2 By Region
- 7.5 Market Analysis and Forecast
- 7.5.1 Total ICD Market
- 7.5.2 Single-Chamber ICD Market
- 7.5.2.1 Initial Placement Single-Chamber ICD Market
- 7.5.2.2 Replacement Single-Chamber ICD Market
- 7.5.3 Dual-Chamber ICD Market
- 7.5.3.1 Initial Placement Dual-Chamber ICD Market
- 7.5.3.2 Replacement Dual-Chamber ICD Market
- 7.5.4 S-ICD Market
- 7.5.4.1 Initial Placement S-ICD Market
- 7.5.4.2 Replacement S-ICD Market
- 7.6 Drivers and Limiters
- 7.6.1 Market Drivers
- 7.6.2 Market Limiters
- 7.7 Competitive Market Share Analysis
- Cardiac Resynchronization Therapy Device Market
- 8.1 Executive Summary
- 8.1.1 Global Cardiac Resynchronization Therapy Device Market Overview
- 8.1.2 Competitive Analysis
- 8.1.3 Procedures Included
- 8.1.4 Markets Included
- 8.1.5 Regions Included
- 8.2 Introduction
- 8.2.1 Cardiac Resynchronization Therapy-Pacemakers (CRT-Ps)
- 8.2.2 Cardiac Resynchronization Therapy-Defibrillators (CRT-Ds)
- 8.3 Procedure Numbers
- 8.3.1 Total CRT Placement Procedures
- 8.3.2 Initial Placement CRT Procedures
- 8.3.3 Replacement CRT Procedures
- 8.4 Market Overview
- 8.4.1 By Segment
- 8.4.2 By Region
- 8.5 Market Analysis and Forecast
- 8.5.1 Total CRT Device Market
- 8.5.2 CRT-P Market
- 8.5.2.1 Initial Placement CRT-P Market
- 8.5.2.2 Replacement CRT-P Market
- 8.5.3 CRT-D Market
- 8.5.3.1 Initial Placement CRT-D Market
- 8.5.3.2 Replacement CRT-D Market
- 8.6 Drivers and Limiters
- 8.6.1 Market Drivers
- 8.6.2 Market Limiters
- 8.7 Competitive Market Share Analysis
- Cardiac Lead Market
- 9.1 Executive Summary
- 9.1.1 Global Cardiac Lead Market Overview
- 9.1.2 Competitive Analysis
- 9.1.3 Markets Included
- 9.1.4 Regions Included
- 9.2 Introduction
- 9.2.1 Replacement of Leads
- 9.3 Market Overview
- 9.3.1 By Segment
- 9.3.2 By Region
- 9.4 Market Analysis and Forecast
- 9.4.1 Total Cardiac Lead Market
- 9.4.2 Pacing Lead Market
- 9.4.3 Defibrillation Lead Market
- 9.4.4 LV Lead Market
- 9.5 Drivers and Limiters
- 9.5.1 Market Drivers
- 9.5.2 Market Limiters
- 9.6 Competitive Market Share Analysis
- Implantable Loop Recorder Market
- 10.1 Executive Summary
- 10.1.1 Global Implantable Loop Recorder Market Overview
- 10.1.2 Competitive Analysis
- 10.1.3 Regions Included
- 10.2 Introduction
- 10.3 Procedure Numbers
- 10.4 Market Analysis and Forecast
- 10.5 Drivers and Limiters
- 10.5.1 Market Drivers
- 10.5.2 Market Limiters
- 10.6 Competitive Market Share Analysis
- Electrophysiology Lab System Market
- 11.1 Executive Summary
- 11.1.1 Global Electrophysiology Lab System Market Overview
- 11.1.2 Competitive Analysis
- 11.1.3 Markets Included
- 11.1.4 Regions Included
- 11.2 Introduction
- 11.2.1 3D Mapping Systems
- 11.2.2 EP Recording Systems
- 11.3 Market Overview
- 11.3.1 By Segment
- 11.3.2 By Region
- 11.4 Market Analysis and Forecast
- 11.4.1 Total Electrophysiology Lab System Market
- 11.4.2 3D Mapping System Market
- 11.4.3 EP Recording System Market
- 11.5 Drivers and Limiters
- 11.5.1 Market Drivers
- 11.5.2 Market Limiters
- 11.6 Competitive Market Share Analysis
- Diagnostic Electrophysiology Catheter Market
- 12.1 Executive Summary
- 12.1.1 Global Diagnostic Electrophysiology Catheter Market Overview
- 12.1.2 Competitive Analysis
- 12.1.3 Markets Included
- 12.1.4 Regions Included
- 12.2 Introduction
- 12.2.1 Diagnostic Electrophysiology Catheters
- 12.2.2 Intracardiac Echocardiography
- 12.3 Procedure Numbers
- 12.4 Market Overview
- 12.4.1 By Segment
- 12.4.2 By Region
- 12.5 Market Analysis and Forecast
- 12.5.1 Total Diagnostic Electrophysiology Catheter Market
- 12.5.2 Conventional Electrophysiology Catheter Market
- 12.5.3 Advanced Electrophysiology Catheter Market
- 12.5.4 ICE Catheter Market
- 12.6 Drivers and Limiters
- 12.6.1 Market Drivers
- 12.6.2 Market Limiters
- 12.7 Competitive Market Share Analysis
- Cardiac Ablation Catheter Market
- 13.1 Executive Summary
- 13.1.1 Global Cardiac Ablation Catheter Market Overview
- 13.1.2 Competitive Analysis
- 13.1.3 Procedures Included
- 13.1.4 Markets Included
- 13.1.5 Regions Included
- 13.2 Introduction
- 13.3 Procedure Numbers
- 13.3.1 Total Cardiac Ablation Procedures
- 13.3.2 RF Ablation Procedures
- 13.3.3 Cryoablation Procedures
- 13.4 Market Overview
- 13.4.1 By Segment
- 13.4.2 By Region
- 13.5 Market Analysis and Forecast
- 13.5.1 Total Cardiac Ablation Catheter Market
- 13.5.2 RF Ablation Catheter Market
- 13.5.3 Cryoablation Catheter Market
- 13.6 Drivers and Limiters
- 13.6.1 Market Drivers
- 13.6.2 Market Limiters
- 13.7 Competitive Market Share Analysis
- Abbreviations
- LIST OF CHARTS
- Chart 1-1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Global, 2021 – 2028
- Chart 1-2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures, Global, 2021
- Chart 2-1: Multi-Scenario Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Forecast, Global, 2018 – 2028 (US$M)
- Chart 5-1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Global, 2018 – 2028
- Chart 5-2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Region, Global, 2018 – 2028
- Chart 5-3: Leading Competitors, Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, Global, 2021
- Chart 6-1: Pacemaker Market, Global, 2018 – 2028
- Chart 6-2: Pacemaker Placement Procedures, Global, 2021
- Chart 6-3: Pacemaker Placement Procedures by Segment, Global, 2018 – 2028
- Chart 6-4: Pacemaker Market by Segment, Global, 2018 – 2028
- Chart 6-5: Pacemaker Market by Region, Global, 2018 – 2028
- Chart 6-6: Leading Competitors, Pacemaker Market, Global, 2021
- Chart 7-1: ICD Market, Global, 2018 – 2028
- Chart 7-2: ICD Placement Procedures, Global, 2021
- Chart 7-3: ICD Placement Procedures by Segment, Global, 2018 – 2028
- Chart 7-4: ICD Market by Segment, Global, 2018 – 2028
- Chart 7-5: ICD Market by Region, Global, 2018 – 2028
- Chart 7-6: Leading Competitors, ICD Market, Global, 2021
- Chart 8-1: CRT Device Market, Global, 2018 – 2028
- Chart 8-2: CRT Device Placement Procedures, Global, 2021
- Chart 8-3: CRT Placement Procedures by Segment, Global, 2018 – 2028
- Chart 8-4: CRT Device Market by Segment, Global, 2018 – 2028
- Chart 8-5: CRT Device Market by Region, Global, 2018 – 2028
- Chart 8-6: Leading Competitors, CRT Device Market, Global, 2021
- Chart 9-1: Cardiac Lead Market, Global, 2018 – 2028
- Chart 9-2: Cardiac Lead Units Sold, Global, 2021
- Chart 9-3: Cardiac Lead Market by Segment, Global, 2018 – 2028
- Chart 9-4: Cardiac Lead Market by Region, Global, 2018 – 2028
- Chart 9-5: Leading Competitors, Cardiac Lead Market, Global, 2021
- Chart 10-1: Implantable Loop Recorder Market, Global, 2018 – 2028
- Chart 10-2: Implantable Loop Recorder Placement Procedures, Global, 2021
- Chart 10-3: Implantable Loop Recorder Placement Procedures by Region, Global, 2018 – 2028
- Chart 10-4: Implantable Loop Recorder Device Market, Global, 2018 – 2028
- Chart 10-5: Leading Competitors, Implantable Loop Recorder Market, Global, 2021
- Chart 11-1: Electrophysiology Lab System Market, Global, 2018 – 2028
- Chart 11-2: Electrophysiology Lab System Procedures, Global, 2021
- Chart 11-3: Electrophysiology Lab System Market by Segment, Global, 2018 – 2028
- Chart 11-4: Electrophysiology Lab System Market by Region, Global, 2018 – 2028
- Chart 11-5: Leading Competitors, Electrophysiology Lab System Market, Global, 2021
- Chart 12-1: Diagnostic Electrophysiology Catheter Market, Global, 2018 – 2028
- Chart 12-2: Diagnostic Electrophysiology Catheter Procedures, Global, 2021
- Chart 12-3: Diagnostic Electrophysiology Procedures, Global, 2018 – 2028
- Chart 12-4: Diagnostic Electrophysiology Catheter Market by Segment, Global, 2018 – 2028
- Chart 12-5: Diagnostic Electrophysiology Catheter Market by Region, Global, 2018 – 2028
- Chart 12-6: Leading Competitors, Diagnostic Electrophysiology Catheter Market, Global, 2021
- Chart 13-1: Cardiac Ablation Catheter Market, Global, 2018 – 2028
- Chart 13-2: Cardiac Ablation Catheter Procedures, Global, 2021
- Chart 13-3: Cardiac Ablation Procedures by Segment, Global, 2018 – 2028
- Chart 13-4: Cardiac Ablation Catheter Market by Segment, Global, 2018 – 2028
- Chart 13-5: Cardiac Ablation Catheter Market by Region, Global, 2018 – 2028
- Chart 13-6: Leading Competitors, Cardiac Ablation Catheter Market, Global, 2021
- LIST OF FIGURES
- Figure 1-1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Share Ranking by Segment, Global, 2021 (1 of 2)
- Figure 1-2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Share Ranking by Segment, Global, 2021 (2 of 2)
- Figure 1-3: Companies Researched in this Report
- Figure 1-4: Factors Impacting the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Global (1 of 2)
- Figure 1-5: Factors Impacting the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Global (2 of 2)
- Figure 1-6: Recent Events in the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, Global, 2018 – 2022 (1 of 2)
- Figure 1-7: Recent Events in the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, Global, 2018 – 2022 (2 of 2)
- Figure 1-8: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures Covered
- Figure 1-9: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Markets Covered (1 of 2)
- Figure 1-10: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Markets Covered (2 of 2)
- Figure 1-11: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Regions Covered, Global (1 of 2)
- Figure 1-12: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Regions Covered, Global (2 of 2)
- Figure 1-13: Version History
- Figure 2-1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Worst Case Scenario, Global, 2018 – 2028 (US$M)
- Figure 2-2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Base Case Scenario, Global, 2018 – 2028 (US$M)
- Figure 2-3: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Best Case Scenario, Global, 2018 – 2028 (US$M)
- Figure 4-1: Pacemaker Market Products by Company
- Figure 4-2: ICD Market Products by Company
- Figure 4-3: CRT Device Market Products by Company (1 of 2)
- Figure 4-4: CRT Device Market Products by Company (2 of 2)
- Figure 4-5: Cardiac Lead Market Products by Company
- Figure 4-6: Implantable Loop Recorder Market Products by Company
- Figure 4-7: EP Lab System Market Products by Company
- Figure 4-8: Diagnostic EP Catheter Market Products by Company
- Figure 4-9: Cardiac Ablation Catheter Products by Company (1 of 2)
- Figure 4-10: Cardiac Ablation Catheter Products by Company (2 of 2)
- Figure 4-11: Class 1 Device Recall Assurity pacemakers
- Figure 4-12: Class 1 Device Recall St. Jude Endurity Pacemakers
- Figure 4-13: Class 1 Device Recall Fortify, Unify, Assura, including Quadra
- Figure 4-14: Class 2 Device Recall Ellipse
- Figure 4-15: Class 2 Device Recall Quadra Assura
- Figure 4-16: Class 2 Device Recall Unify Assura
- Figure 4-17: Class 2 Device Recall Unify Quadra
- Figure 4-18: Class 2 Device Recall Promote Quadra
- Figure 4-19: Class 2 Device Recall Allure Quadra
- Figure 4-20: Class 2 Device Recall Allure Quadra
- Figure 4-21: Class 2 Device Recall Anthem, Allure
- Figure 4-22: Class 2 Device Recall Nuance
- Figure 4-23: Class 1 Device Recall Optisure HV lead
- Figure 4-24: Class 2 Device Recall FIRMap
- Figure 4-25: Class 2 Device Recall WorkMate Claris, v.1.2 Upgrade Kits
- Figure 4-26: Class 3 Device Recall FIRMap 60mm Catheter
- Figure 4-27: Class 2 Device Recall Abbott
- Figure 4-28: Class 2 Device Recall TactiSys Quartz Pack, PN004 400
- Figure 4-29: Class 2 Device Recall CARTO 3 System
- Figure 4-30: Class 2 Device Recall SMARTABLATE RF Generator System
- Figure 4-31: Class 2 Device Recall ACUSON AcuNav Volume ICE Catheter
- Figure 4-32: Class 2 Device Recall PENTARAY NAV eco HighDensity Mapping Catheter
- Figure 4-33: Class 2 Device Recall PENTARAY NAV HighDensity Mapping Catheter
- Figure 4-34: Class 2 Device Recall SOUNDSTAR eco Catheter
- Figure 4-35: Class 2 Device Recall WEBSTER Fixed Curve Catheter with Auto ID Technology
- Figure 4-36: Class 2 Device Recall THERMOCOOL SMARTTOUCH
- Figure 4-37: Class 1 Device Recall ADVANTIO DR EL
- Figure 4-38: Class 1 Device Recall INGENIO DR EL
- Figure 4-39: Class 1 Device Recall VITALIO DR EL
- Figure 4-40: Class 2 Device Recall Accolade
- Figure 4-41: Class 2 Device Recall Essentio
- Figure 4-42: Class 2 Device Recall EMBLEM
- Figure 4-43: Class 1 Device Recall EMBLEM
- Figure 4-44: Class 2 Device Recall ESSENTIO Pacemaker
- Figure 4-45: Class 2 Device Recall PROPONENT Pacemaker
- Figure 4-46: Class 2 Device Recall ACCOLADE Pacemaker
- Figure 4-47: Class 2 Device Recall ACCOLADE MRI Pacemaker
- Figure 4-48: Class 2 Device Recall ESSENTIO MRI Pacemaker
- Figure 4-49: Class 2 Device Recall ESSENTIO Pacemaker
- Figure 4-50: Class 2 Device Recall PROPONENT Pacemaker
- Figure 4-51: Class 2 Device Recall PROPONENT MRI Pacemaker
- Figure 4-52: Class 2 Device Recall ALTRUA 2 EL DR Pacemaker
- Figure 4-53: Class 2 Device Recall ALTRUA 2 SR Pacemaker
- Figure 4-54: Class 2 Device Recall ALTRUA 2 DR Pacemaker
- Figure 4-55: Class 2 Device Recall Accolade MRI and Essentio MRI pacemakers
- Figure 4-56: Class 2 Device Recall EMBLEM
- Figure 4-57: Class 2 Device Recall EMBLEM
- Figure 4-58: Class 1 Device Recall EMBLEM
- Figure 4-59: Class 2 Device Recall DYNAGEN EL ICD DR
- Figure 4-60: Class 2 Device Recall Implantable Cardioverter Defibrillator (NonCRT)
- Figure 4-61: Class 2 Device Recall RESONATE EL ICD VR/DR
- Figure 4-62: Class 2 Device Recall EMBLEM SICD, Model A209
- Figure 4-63: Class 2 Device Recall SQRX 1010 Pulse Generator
- Figure 4-64: Class 2 Device Recall EMBLEM MRI SICD Model 219
- Figure 4-65: Class 2 Device Recall SQRX Model 1010 Subcutaneous Pulse Generator
- Figure 4-66: Class 1 Device Recall INTUA CRTP
- Figure 4-67: Class 1 Device Recall INVIVE CRTP
- Figure 4-68: Class 2 Device Recall VISIONIST CRTP
- Figure 4-69: Class 2 Device Recall VALITUDE CRTP
- Figure 4-70: Class 2 Device Recall VALITUDE X4 CRTP (Cardiac Resynchronization Therapy Pacemaker)
- Figure 4-71: Class 2 Device Recall VALITUDE X4 CRTP Pacemaker
- Figure 4-72: Class 2 Device Recall VALITUDE CRTP Pacemaker
- Figure 4-73: Class 2 Device Recall VISIONIST X4 CRTP Pacemaker
- Figure 4-74: Class 2 Device Recall VISIONIST CRTP Pacemaker
- Figure 4-75: Class 2 Device Recall RESONATE X4 CRTD
- Figure 4-76: Class 2 Device Recall MOMENTUM X4 CRTD
- Figure 4-77: Class 2 Device Recall VIGILANT X4 CRTD
- Figure 4-78: Class 2 Device Recall Boston Scientific, INGEVITY MRI Leads, Sterile EO, RxOnly
- Figure 4-79: Class 2 Device Recall iLab Polaris MultiModality Guidance System
- Figure 4-80: Class 2 Device Recall Maestro 4000 Cardiac Ablation System
- Figure 4-81: Class 2 Device Recall CLEARSIGN II Amplifier for LABSYSTEM PRO EP Recording System
- Figure 4-82: Class 3 Device Recall Cardiac Ablation Percutaneous Catheters
- Figure 4-83: Class 1 Device Recall Intella Tip MiFi Open Irrigated Ablation Catheter
- Figure 4-84: Class 2 Device Recall Astra XT DR Implantable pulse generator
- Figure 4-85: Class 2 Device Recall Azure
- Figure 4-86: Class 2 Device Recall Azure XT DR MRI
- Figure 4-87: Class 2 Device Recall Azure S DR MRI
- Figure 4-88: Class 2 Device Recall Azure XT SR MRI
- Figure 4-89: Class 2 Device Recall Azure S SR MRI
- Figure 4-90: Class 2 Device Recall Medtronic Micra MC1VR01
- Figure 4-91: Class 1 Device Recall SPHERA, Dual chamber pacemaker
- Figure 4-92: Class 1 Device Recall SENSIA, Dual chamber pacemaker
- Figure 4-93: Class 1 Device Recall VERSA, Dual chamber pacemaker
- Figure 4-94: Class 1 Device Recall ADAPTA, Dual chamber pacemaker
- Figure 4-95: Class 1 Device Recall ATTESTA L DR MRI SureScan, Dual chamber rate responsive pacemaker
- Figure 4-96: Class 2 Device Recall Medtronic Model 53401 Single Chamber External Pulse Generator
- Figure 4-97: Class 2 Device Recall Medtronic Model 5392 Dual Chamber Temporary External Pulse Generator
- Figure 4-98: Class 1 Device Recall Cobalt
- Figure 4-99: Class 1 Device Recall Crome
- Figure 4-100: Class 1 Device Recall Evera and Visia
- Figure 4-101: Class 2 Device Recall EnTrust Dual Chamber Implantable Cardioverter Defibrillator with Atrial and Ventricular Therapies
- Figure 4-102: Class 2 Device Recall EnTrust Single Chamber Implantable Cardioverter Defibrillator with Atrial and Ventricular Therapies
- Figure 4-103: Class 2 Device Recall Medtronic EnTrust Escudo
- Figure 4-104: Class 1 Device Recall Evera MRI XT DR ICD, Evera MRI XT VR ICD, Evera MRI S DR ICD
- Figure 4-105: Class 1 Device Recall Visia AF MRI VR SureScan ICD
- Figure 4-106: Class 1 Device Recall Visia AF VR ICD
- Figure 4-107: Class 1 Device Recall Evera S DR ICD, Evera S VR ICD, Evera XT DR ICD, Evera XT VR ICD
- Figure 4-108: Class 2 Device Recall Evera ICD
- Figure 4-109: Class 2 Device Recall Viva ICD
- Figure 4-110: Class 1 Device Recall Cobalt
- Figure 4-111: Class 1 Device Recall Crome
- Figure 4-112: Class 2 Device Recall Cobalt
- Figure 4-113: Class 2 Device Recall Precepta
- Figure 4-114: Class 2 Device Recall Percepta, Serena, and Solara CRTP MRI
- Figure 4-115: Class 1 Device Recall Viva, Claria, Amplia, Compia, and Brava
- Figure 4-116: Class 2 Device Recall Percepta CRTP MRI
- Figure 4-117: Class 2 Device Recall Solara CRTP MRI
- Figure 4-118: Class 2 Device Recall Serena CRTP MRI
- Figure 4-119: Class 2 Device Recall Percepta CRTP MRI SureScan
- Figure 4-120: Class 2 Device Recall Percepta Quad CRTP MRI SureScan
- Figure 4-121: Class 1 Device Recall Amplia MRI CRTD, Amplia MRI Quad CRTD
- Figure 4-122: Class 1 Device Recall Viva Quad S CRTD, Viva Quad XT CRTD, Viva S CRTD, Viva XT CRTD
- Figure 4-123: Class 1 Device Recall Compia MRI CRTD, Compia MRI Quad CRTD
- Figure 4-124: Class 2 Device Recall Amplia MRI Quad CRT0 SureScanClaria MRI Quad CRTD SureScanCompia MRI Quad CRTD SureScan
- Figure 4-125: Class 2 Device Recall InSync III
- Figure 4-126: Class 2 Device Recall Sprint Quattro
- Figure 4-127: Class 2 Device Recall Medtronic, Temporary Pacing Lead System
- Figure 4-128: Class 2 Device Recall Achieve Electrical Cable
- Figure 4-129: Class 2 Device Recall Medtronic CryoConsole
- Figure 4-130: Class 2 Device Recall Platinium Implantable Cardiac Defibrillator and Resynchronization Therapy Defibrillator
- Figure 4-131: Class 2 Device Recall Platinium DR 1510
- Figure 4-132: Class 2 Device Recall Platinium VR 1210
- Figure 4-133: Class 2 Device Recall Platinium DR DF4 1540
- Figure 4-134: Class 2 Device Recall Platinium VR DF4 1240
- Figure 4-135: Class 2 Device Recall PARADYM
- Figure 4-136: Class 2 Device Recall OVATIO
- Figure 4-137: Class 2 Device Recall INTENSIA
- Figure 4-138: Class 2 Device Recall Platinium Implantable Cardiac Defibrillator and Resynchronization Therapy Defibrillator
- Figure 4-139: Class 2 Device Recall Platinium CRTD 1741
- Figure 4-140: Class 2 Device Recall Platinium CRT DF1 1711
- Figure 4-141: Class 2 Device Recall PARADYM
- Figure 4-142: Class 2 Device Recall OVATIO
- Figure 4-143: Class 2 Device Recall INTENSIA
- Figure 4-144: The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System
- Figure 4-145: Aveir VR Coverage With Evidence Development Post-Approval Study (CED)
- Figure 4-146: A Retrospective Trial to Evaluate the Micra Pacemaker (Micra)
- Figure 4-147: Project My Heart Your Heart: Pacemaker Reuse (MHYH)
- Figure 4-148: Evaluation of Atrial Fibrillation Occurrence in Sick Sinus and Complete Atrioventricular Block Patients After Pacemaker Implantation (AF-pacemaker Study)
- Figure 4-149: Longitudinal Coverage With Evidence Development Study on Micra Leadless Pacemakers
- Figure 4-150: Heart Failure Indication and Sudden Cardiac Death Prevention Trial Japan
- Figure 4-151: BIO|MASTER.Edora Family Study
- Figure 4-152: China Micra Transcatheter Pacing Study
- Figure 4-153: Optimizing Pacemaker Therapy Using Multi-Point Pacing (the OPT-MPP Study)
- Figure 4-154: Electrical Cardioversion, Ablation or Pace and Ablate for Persistent Atrial Fibrillation - The CAPAPAF-65 Study
- Figure 4-155: Advanced Bradycardia Device Feature Utilization and Clinical Outcomes II
- Figure 4-156: Observation of ImageReady™ MR Conditional Pacing System in China
- Figure 4-157: Micra Transcatheter Pacing System Continued Access Study Protocol
- Figure 4-158: Extravascular ICD Pivotal Study (EV ICD)
- Figure 4-159: Defibrillation Testing During Implantable Cardioverter Defibrillator (ICD) Replacement (T-DEF)
- Figure 4-160: Master Study of the Acticor/Rivacor ICDs/CRT-Ds and the Plexa ProMRI S DX Lead
- Figure 4-161: A Post-market Clinical Evaluation of St. Jude Medical™ MR Conditional ICD System on Patients Undergoing Magnetic Resonance Imaging (ASIA MRI ICD)
- Figure 4-162: Effectiveness of the EMPOWER™ Modular Pacing System and EMBLEM™ Subcutaneous ICD to Communicate Antitachycardia Pacing (MODULAR ATP)
- Figure 4-163: Acute Feasibility Investigation of a New S-ICD Electrode (ASE)
- Figure 4-164: Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED)
- Figure 4-165: A PRospective, rAndomizEd Comparison of subcuTaneOous and tRansvenous ImplANtable Cardioverter Defibrillator Therapy (PRAETORIAN)
- Figure 4-166: Comparison of CRT-D and CRT-DX Systems (CRT-NEXT)
- Figure 4-167: Increasing Detection of Sub-Clinical Atrial Fibrillation in Defibrillator Patients with the Use of a VDD-ICD Lead (Dx-AF)
- Figure 4-168: Multicenter Automatic Defibrillator Implantation Trial with Subcutaneous Implantable Cardioverter Defibrillator (MADIT S-ICD)
- Figure 4-169: Extravascular ICD Pilot Study
- Figure 4-170: Acute Feasibility Investigation of a New S-ICD Electrode
- Figure 4-171: Subcutaneous ICD Therapy Combined with VT Ablation for the Secondary Prevention of Sudden Cardiac Death
- Figure 4-172: BIO|MASTER.Ilivia Family/Plexa
- Figure 4-173: Metabolic Mapping and Cardiac Resynchronization
- Figure 4-174: CRT-P or CRT-D in Dilated Cardiomyopathy (CRT-REALITY)
- Figure 4-175: Safety and Performance Aspects of CRT-DX System in Patients with Sinus Rhythm (BIO|REDUCE)
- Figure 4-176: Prospective Randomized Trial Comparing TRIPLE Site ventricular Stimulation Versus Conventional Pacing in CRT candidates: TRIPLEAD Trial
- Figure 4-177: Re-evaluation of Optimal Re-synchronization Therapy in Patients with Chronic Heart Failure
- Figu
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook